Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 09, 2020 Filed Nov 9, 2020 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
SaleCommon Stock | 5,531 | $147.36 | $815,069.73 |
DisclosureSEC source: 0001209191-20-057537 · doc4.xml · nonDerivative · entry 9 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,531.7241 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.29 to $147.47, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Includes 1,927.7241 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| November 09, 2020 Filed Nov 9, 2020 21:11 UTC |
Paslick P. MartinSVP and CIO
|
SaleCommon Stock | 3,948 | $148.07 | $584,583.12 |
DisclosureSEC source: 0001209191-20-057536 · doc4.xml · nonDerivative · entry 3 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.94 to $148.17, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 9, 2020 21:08 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
SaleCommon Stock | 1,745 | $152.50 | $266,112.50 |
DisclosureSEC source: 0001209191-20-057534 · doc4.xml · nonDerivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,509 F1 · kind: The sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 09, 2020 Filed Nov 9, 2020 21:08 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
SaleCommon Stock | 1,745 | $147.00 | $256,515.00 |
DisclosureSEC source: 0001209191-20-057534 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,254 F1 · kind: The sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 20:42 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Exercise / conversionStock Appreciation Right · Derivative | 7,500 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-20-058190 · doc4.xml · derivative · entry 11 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,750 Underlying: Common Stock · 7,500 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 20:42 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Exercise / conversionStock Appreciation Right · Derivative | 30,000 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-20-058190 · doc4.xml · derivative · entry 10 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 20:42 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Tax withholdingCommon Stock | 20,498 | $147.32 | $3,019,765.36 |
DisclosureSEC source: 0001209191-20-058190 · doc4.xml · nonDerivative · entry 2 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,533.7241 Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 20:42 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Exercise / conversionCommon Stock | 37,500 | $37.18 | $1,394,250.00 |
DisclosureSEC source: 0001209191-20-058190 · doc4.xml · nonDerivative · entry 1 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,031.7241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 20:38 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionStock Appreciation Right · Derivative | 10,000 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-20-058186 · doc4.xml · derivative · entry 4 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,525 Underlying: Common Stock · 10,000 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 20:38 UTC |
Paslick P. MartinSVP and CIO
|
Tax withholdingCommon Stock | 5,911 | $147.32 | $870,808.52 |
DisclosureSEC source: 0001209191-20-058186 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,089 Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 20:38 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionCommon Stock | 10,000 | $47.97 | $479,700.00 |
DisclosureSEC source: 0001209191-20-058186 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2020 Filed Feb 5, 2021 20:30 UTC |
RUTHERFORD BILL BCFO and EVP
|
GiftCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008352 · doc4.xml · nonDerivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,409 Read SEC document |
| November 05, 2020 Filed Nov 5, 2020 19:53 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionNon- Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $22.10 | $0.00 |
DisclosureSEC source: 0001209191-20-057213 · doc4.xml · derivative · entry 15 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| November 05, 2020 Filed Nov 5, 2020 19:53 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionNon- Qualified Stock Option (right to buy) · Derivative | 6,250 | $0.00 Strike: $21.35 | $0.00 |
DisclosureSEC source: 0001209191-20-057213 · doc4.xml · derivative · entry 14 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,250 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2020 Filed Nov 5, 2020 19:53 UTC |
RUTHERFORD BILL BCFO and EVP
|
SaleCommon Stock | 36,250 | $139.33 | $5,050,676.25 |
DisclosureSEC source: 0001209191-20-057213 · doc4.xml · nonDerivative · entry 6 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,659 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.00 to $139.93, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 05, 2020 Filed Nov 5, 2020 19:53 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionCommon Stock | 5,000 | $22.10 | $110,500.00 |
DisclosureSEC source: 0001209191-20-057213 · doc4.xml · nonDerivative · entry 5 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2020 Filed Nov 5, 2020 19:53 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionCommon Stock | 6,250 | $21.35 | $133,437.50 |
DisclosureSEC source: 0001209191-20-057213 · doc4.xml · nonDerivative · entry 4 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Exercise / conversionStock Appreciation Right · Derivative | 12,500 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-20-057537 · doc4.xml · derivative · entry 12 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 12,500 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Tax withholdingCommon Stock | 6,969 | $137.56 | $958,655.64 |
DisclosureSEC source: 0001209191-20-057537 · doc4.xml · nonDerivative · entry 8 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,062.7241 F1 · balance_after: Includes 1,927.7241 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Exercise / conversionCommon Stock | 12,500 | $37.18 | $464,750.00 |
DisclosureSEC source: 0001209191-20-057537 · doc4.xml · nonDerivative · entry 7 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,031.7241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,927.7241 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:10 UTC |
Hall Charles JGroup President
|
SaleCommon Stock | 15,000 | $139.36 | $2,090,425.50 |
DisclosureSEC source: 0001209191-20-057535 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,203 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.17 to $139.51, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:11 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionStock Appreciation Right · Derivative | 3,025 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-20-057536 · doc4.xml · derivative · entry 6 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,025 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:11 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionStock Appreciation Right · Derivative | 6,975 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-20-057536 · doc4.xml · derivative · entry 5 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,525 Underlying: Common Stock · 6,975 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:11 UTC |
Paslick P. MartinSVP and CIO
|
Tax withholdingCommon Stock | 6,052 | $137.56 | $832,513.12 |
DisclosureSEC source: 0001209191-20-057536 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,948 Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:11 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionCommon Stock | 10,000 | $47.97 | $479,700.00 |
DisclosureSEC source: 0001209191-20-057536 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:08 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
SaleCommon Stock | 1,745 | $139.50 | $243,427.50 |
DisclosureSEC source: 0001209191-20-057534 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,999 F1 · kind: The sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:08 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
SaleCommon Stock | 3,472 | $139.19 | $483,257.96 |
DisclosureSEC source: 0001209191-20-057533 · doc4.xml · nonDerivative · entry 1 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,375 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.14 to $139.21, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 04, 2020 Filed Feb 5, 2021 20:26 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 34,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008343 · doc4.xml · nonDerivative · entry 4 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 34,039 Read SEC document |
| November 04, 2020 Filed Feb 5, 2021 20:26 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 34,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008343 · doc4.xml · nonDerivative · entry 3 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 04, 2020 Filed Feb 5, 2021 20:26 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 34,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008343 · doc4.xml · nonDerivative · entry 2 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By JMF Trust (Spouse and Robert Nagel, Co-Trustees) Disclosed balance after: 44,039 Read SEC document |
| November 04, 2020 Filed Feb 5, 2021 20:26 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 34,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008343 · doc4.xml · nonDerivative · entry 1 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,039 Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 19:54 UTC |
Paslick P. MartinSVP and CIO
|
SaleCommon Stock | 1,771 | $133.50 | $236,428.50 |
DisclosureSEC source: 0001209191-20-057214 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | Exercise / conversionStock Appreciation Right · Derivative | 90,250 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · derivative · entry 18 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,250 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | Exercise / conversionStock Appreciation Right · Derivative | 95,000 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · derivative · entry 17 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 95,000 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | Exercise / conversionStock Appreciation Right · Derivative | 125,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · derivative · entry 16 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | Exercise / conversionStock Appreciation Right · Derivative | 125,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · derivative · entry 15 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $22.10 | $0.00 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · derivative · entry 14 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,625 | $0.00 Strike: $21.35 | $0.00 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · derivative · entry 13 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,625 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 46,875 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · derivative · entry 12 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,875 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested in three equal installments at the end of fiscal years 2012, 2013 and 2014 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 46,875 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · derivative · entry 11 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,875 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in three equal annual installments beginning on November 2, 2013. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | SaleCommon Stock | 44,099 | $135.02 | $5,954,233.75 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · nonDerivative · entry 9 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,476 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.44 to $135.43, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | SaleCommon Stock | 72,776 | $135.90 | $9,890,440.34 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · nonDerivative · entry 8 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,575 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.44 to $136.43, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | SaleCommon Stock | 5,000 | $136.63 | $683,164.50 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · nonDerivative · entry 7 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385,351 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.50 to $136.82, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | Tax withholdingCommon Stock | 227,540 | $136.09 | $30,965,918.60 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · nonDerivative · entry 6 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,351 Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | Exercise / conversionCommon Stock | 185,250 | $37.18 | $6,887,595.00 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · nonDerivative · entry 5 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | Exercise / conversionCommon Stock | 250,000 | $22.95 | $5,737,500.00 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · nonDerivative · entry 4 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | Exercise / conversionCommon Stock | 12,500 | $22.10 | $276,250.00 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · nonDerivative · entry 3 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | Exercise / conversionCommon Stock | 15,625 | $21.35 | $333,593.75 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:52 UTC | Exercise / conversionCommon Stock | 93,750 | $17.33 | $1,624,687.50 |
DisclosureSEC source: 0001209191-20-057212 · doc4.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| November 03, 2020 Filed Nov 5, 2020 19:53 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionStock Appreciation Right · Derivative | 8,075 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-20-057213 · doc4.xml · derivative · entry 13 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,075 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.